In multivariate analysis adjusted for the Child–Pugh system (Class A vs. Class B), α-fetoprotein (< 400 vs. ≥ 400), age (< 75 vs. ≥ 75), albumin-bilirubin (ALBI) grade (Grade 1 vs. Grade ≥ 2), Barcelona Clinic Liver Cancer (BCLC) staging system (Stage B vs. Stage C), Macroscopic portal vein invasion, extrahepatic spread, or both, present (no vs. yes), and relative dose intensities at 56 days (≥ 80% vs. < 80%). Here, ALB is linked to liver cancer.